Cargando…
Dysregulated expression levels of APH1B in peripheral blood are associated with brain atrophy and amyloid-β deposition in Alzheimer’s disease
BACKGROUND: The interaction between the brain and periphery might play a crucial role in the development of Alzheimer’s disease (AD). METHODS: Using blood transcriptomic profile data from two independent AD cohorts, we performed expression quantitative trait locus (cis-eQTL) analysis of 29 significa...
Autores principales: | Park, Young Ho, Pyun, Jung-Min, Hodges, Angela, Jang, Jae-Won, Bice, Paula J., Kim, SangYun, Saykin, Andrew J., Nho, Kwangsik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567578/ https://www.ncbi.nlm.nih.gov/pubmed/34732252 http://dx.doi.org/10.1186/s13195-021-00919-z |
Ejemplares similares
-
Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology
por: Pyun, Jung‐Min, et al.
Publicado: (2022) -
miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease
por: Han, Sang-Won, et al.
Publicado: (2023) -
BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2021) -
Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2022) -
Association of blood-based transcriptional risk scores with biomarkers for Alzheimer disease
por: Park, Young Ho, et al.
Publicado: (2020)